HIGHLIGHTS
- who: Biotechnology and collaborators from the Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China, Zhejiang University-University of Edinburgh Institute, Haining, China have published the paper: Therapeutic Effects of Zoledronic Acid-Loaded Hyaluronic Acid/ Polyethylene Glycol/ Nano-Hydroxyapatite Nanoparticles on Osteosarcoma, in the Journal: (JOURNAL)
- what: The authors designed nearly 100-nm inorganic NPs modified with HA and PEG on nHA, which can load ZOL to target osteosarcoma cells. The authors intended to research whether the NPs could induce tumor cell apoptosis and necrosis directly . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.